FBIO

Fortress Biotech, Inc. (NASDAQ:FBIO) is a biopharmaceutical company founded in 2006 and originally incorporated as Coronado Biosciences before changing its name in April 2015. Based in Bay Harbor Island, New York, the company has evolved from its early focus on inflammatory bowel disease treatments to become a diversified biotechnology enterprise that both develops novel therapeutics and commercializes approved pharmaceutical products. The company operates through a unique business model that combines immediate revenue generation from marketed dermatology products with a robust pipeline of experimental treatments spanning oncology, rare diseases, and gene therapies.